Combination therapy for selected sex steroid dependent cancers

Details Combination therapy for selected sex steroid dependent cancers Combination therapy for selected sex steroid dependent cancers

1986-07-31

1988-07-26

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514177, 514178, 514800, 514358, A61K 3743

Patent

active

047600535

ABSTRACT:
A combination therapy for treatment of selected sex steroid dependent cancers in susceptible warm-blooded animals comprising administering to such animals whose hormone output of their testes or ovaries, respectively, is blocked a therapeutically effective amount of an antiandrogen and/or an antiestrogen and/or at least one inhibitor of sex steroid biosynthesis or pharmaceutical compositions thereof wherein the selected sex steroid dependent cancer are, for example, testicular cancer, ovarian cancer, renal cancer or uterine cancer is disclosed.

REFERENCES:
patent: 4024248 (1977-05-01), Konig et al.
patent: 4071622 (1978-01-01), Johnson et al.
patent: 4094994 (1978-06-01), Schonenberger et al.
patent: 4097578 (1978-06-01), Perronnet et al.
patent: 4100274 (1978-07-01), Du Ha et al.
patent: 4118483 (1978-10-01), Konig et al.
patent: 4234571 (1980-11-01), Nestor et al.
patent: 4239776 (1980-12-01), Glen et al.
patent: 4291028 (1981-09-01), Vorys
patent: 4292315 (1981-09-01), Vorys
patent: 4329364 (1982-05-01), Neri et al.
patent: 4386080 (1983-05-01), Crowley et al.
patent: 4415553 (1983-11-01), Zhabilov et al.
patent: 4472382 (1984-09-01), Labrie et al.
patent: 4481190 (1984-11-01), Nestor et al.
patent: 4530920 (1985-07-01), Nestor et al.
patent: 4632979 (1986-12-01), Coy et al.
patent: 4650787 (1987-03-01), Schally et al.
patent: 4667014 (1987-05-01), Nestor, Jr. et al.
Cancer Treatment Reports, vol. 68 (No. 1) pp. 281-289 (1984), A. V. Schally et al.
Proc. Natl. Acad. Sci. U.S.A., vol. 80, pp. 1459-1462 (1983), T. W. Redding and A. V. Schally.
"LH-RH Analogs in the Treatment of Human Breast Cancer", H. A. Harvey et al. in LHRH and Its Analogs-A New Class of Contraceptive and Therapeutic Agents, pp. 329-335 (B. H. Vickery et al. etc.) MTP Press Lancaster URI.
Lancet, 1, 1213-1216 (1982), J. G. M. Klijn et al. (The Lancet, May 29, 1982).
Cancer, vol. 50, 1708-1712 (1982), A. V. Buzdar et al.
Lancet, 1204-1207 (1973), H. Flax et al. (The Lancet; Jun. 2, 1973).
The Prostate, vol. 4, 579-594 (1983), F. Labrie et al.
J. Steroid Biochem., vol. 19, 99-1007 (1983), F. Labrie et al.
Cancer Treatment Review, vol. 5, 131-141 (1978), H. Movridsen et al.
J. Steroid Biochem. vol. 20 (No. 6B) 1381 (1984), J. G. M. Klijn et al.
J. Med. Chem., vol. 21, 1018-10214 (1978), A. S. Dutta et al.
Biochem. Biophy. Res. Commun., vol. 100, pp. 915-920 (1981), J. Erchegg et al.
Endrocrinology, vol. 110, pp. 1445-1447 (1982); D. H. Coy et al.
J. Steroid Biochem., vol. 20 (No. 6B), 1366 (1984); J. I. Nestor et al.
J. Steroid Biochem. vol. 20, (No. 6B) 1365 (1984); J. Rivier et al.
J. Steroid Biochem., vol. 20 (No. 6B) p. 1369 (1984); A. Corbin et al.
LH-RH and Its Analogs (B. H. Vickery et al. Editors), pp. 3-10, J. J. Nestor.
LH-RH and Its Analogs (B. H. Vickery et al. Editors), pp. 11-22, J. Rivier et al.
LH-RH and Its Analogs (B. H. Vickery et al. Editors) pp. 23-33, J. J. Nestor et al.
"Solid Phase Peptide Synthesis" Stewart et al. Freman and Co., San Francisco, Calif. (1969). pp. 1-26.
J. Med. Chem. vol. 19, pp. 423-425 (1976) D. H. Coy et al.
LHRH and Its Analogs (B. H. Vickery et al, eds.) pp. 337-350, N. Faure et al.
LH-RH and Its Analogs (B. H. Vickery et al, eds.), pp. 351-364, R. J. Santen et al.
J. Steroid Biochem., vol. 20 (No. 6B) p. 1375 (1984); R. Santen et al.
J. Steroid Biochem, vol. 20 (No. 6B) p. 1395 (1984); D. Kerle et al.
Abstr. 7th Internat'l Cong. Endocrin., Excerpta Medica (1984) p. 98; F. Labrie et al.
J. Androl., vol. 1, pp. 209-228 (1984); F. Labrie et al.
Lancet, I, pp. 971-972 (1984); Kahan et al.

Affiliated with

Also associated with

Rating

Combination therapy for selected sex steroid dependent cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for selected sex steroid dependent cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for selected sex steroid dependent cancers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-257986